854700-38-2

Basic information

• Product Name: 2-(4-NITRO-PHENYL)-1H-IMIDAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
• Synonyms: 2-(4-NITRO-PHENYL)-1H-IMIDAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
• CAS NO: 854700-38-2
• Molecular Formula: C₁₂H₁₁N₃O₄
• Molecular Weight: 261.23
• Mol File: 854700-38-2.mol

Chemical Properties

• Melting Point: 215 °C
• Boiling Point: 503.7±40.0 °C(Predicted)
• Appearance: /
• Density: 1.357±0.06 g/cm3(Predicted)
• PKA: 9.04±0.10(Predicted)
• CAS DataBase Reference: 2-(4-NITRO-PHENYL)-1H-IMIDAZOLE-4-CARBOXYLIC ACID ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-NITRO-PHENYL)-1H-IMIDAZOLE-4-CARBOXYLIC ACID ETHYL ESTER(854700-38-2)
• EPA Substance Registry System: 2-(4-NITRO-PHENYL)-1H-IMIDAZOLE-4-CARBOXYLIC ACID ETHYL ESTER(854700-38-2)

Safety Data

• Hazardous Substances Data: 854700-38-2(Hazardous Substances Data)

Usage

Type of compound

Organic compound

Structure

Nitroimidazole derivative with a nitro group attached to a phenyl ring and an imidazole ring, and a carboxylic acid ethyl ester functional group

Usage

Commonly used in the synthesis of pharmaceuticals and research chemicals

Bioactivity

Has potential applications in the pharmaceutical industry due to its bioactive properties and ability to interact with biological systems

Synthesis

Used as a key intermediate in the synthesis of various biologically active compounds

Upstream product

• 100-19-6 (4-nitrophenyl)ethanone 
• 623-73-4 diazoacetic acid ethyl ester 
• 937-31-5 (4-Nitrophenyl)acetylene 
• 54808-56-9 4-(4-nitrophenyl)-2,4-dione-butyric acid ethyl ester 

Downstream Products

• 1257427-52-3 1-[3-(9H-carbazol-4-yloxy)-2-hydroxypropyl]-3-(4-nitrophenyl)-1H-pyrazole-5-carboxylic acid 
• 1316754-44-5 C₂₃H₂₆N₆O₃ 
• 189083-63-4 C₁₀H₇N₃O₄ 

Relevant articles and documents

Substituted pyrazole-containing compound, preparation method and applications thereof

The present invention provides a substituted pyrazole-containing compound, a preparation method and applications thereof, wherein the compound or a pharmaceutically acceptable salt thereof has a structure represented by a formula X defined in the specific

Synthesis and anti-inflammatory activity of some novel 3-phenyl-N-[3-(4- phenylpiperazin-1yl)propyl]-1H-pyrazole-5-carboxamide derivatives

A new series of 3-phenyl-N-[3-(4-phenylpiperazin-1yl)propyl]-1H-pyrazole-5- carboxamide derivatives were synthesized and investigated their anti-inflammatory activities using carrageenan-induced rat paw edema model in vivo. All the synthesized compounds were found to be potent anti-inflammatory agents.

Synthesis and cytotoxicity evaluation of 1-[3-(9H-carbazol-4-yloxy)-2- hydroxypropyl]-3-aryl-1H-pyrazole-5-carboxylic acid derivatives

Several novel molecules, 1-(3′-(9H-carbazol-4-yloxy)-2′- hydroxypropyl)-3-aryl-1H-pyrazole-5-carboxylic acid derivatives 3a-g were synthesized and screened to evaluate their cytotoxicity against cancer cells in vitro. The compounds 3a-g has been prepared by the reaction of ethyl 3-aryl-1H-pyrazole-5-carboxylate with 4-oxiranylmethoxy-9H-carbazole in moderate to excellent yields. The cytotoxicity of synthesized compounds was evaluated by a SRB (sulforhodamine B) assay against cancer cell such as SK-N-SH human neuroblastoma (NB), human A549 lung carcinoma, human breast cancer MCF-7 cell lines. The results showed that seven compounds can suppress SK-N-SH tumor cancer cell growth. Among them, compound 3d was the most effective small molecule in inhibiting SK-N-SH cell growth.

1,3-Dipolar cycloaddition of diazoacetate compounds to terminal alkynes promoted by Zn(OTf)2: an efficient way to the preparation of pyrazoles

A series of pyrazoles were prepared in good yields via 1,3-dipolar cycloaddition of diazoacetate compounds to terminal alkynes promoted by Zn(OTf)2 under mild conditions. It was supposed that the reaction was through the intermediate of Zn alky